Global Pharma Healthcare Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Global Pharma Healthcare Private Limited Pharmaceutical Export Portfolio Dataset — 6 Products, $3.2M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Global Pharma Healthcare Private Limited — Pharmaceutical Exporter Profile (2026) | 6 Products, $3.2M Trade | TransData Nexus

Global Pharma Healthcare Private Limited

Indian Pharmaceutical Exporter · Respiratory Specialist · $3.2M Total Trade · DGFT Verified

Global Pharma Healthcare Private Limited is an Indian pharmaceutical exporter with a total trade value of $3.2M across 6 products in 5 therapeutic categories. Based on 104 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Prednisolone ($2.7M), Vildagliptin ($146.5K), Roxithromycin ($135.0K).

Global Pharma Healthcare Private Limited — Export Portfolio & Destination Treemap

Global Pharma Healthcare Private Limited pharmaceutical export portfolio — 6 products across 5 therapeutic categories. Source: Indian Customs (DGFT).

Who is Global Pharma Healthcare Private Limited? — Company Overview & Market Position

Global Pharma Healthcare Private Limited, established in 1986, is a privately held pharmaceutical company headquartered in Chennai, Tamil Nadu, India. The company is registered under the Corporate Identification Number (CIN) U51102TN1986PTC013099. As of March 2022, Global Pharma reported a paid-up capital of ₹11.60 crore, with an authorized capital of ₹12.50 crore. The company's registered office is located at Third Floor, 2A Ganga Nagar, Fourth Street, Kodambakkam, Chennai, Tamil Nadu, 600024, India.

Global Pharma specializes in the manufacturing and export of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections. The company has a significant presence in over 40 countries, with more than 700 product registrations. Their manufacturing facility in Chennai spans over 75,000 square feet and is certified by EU-GMP and WHO-GMP standards, ensuring high-quality production processes.

What Does Global Pharma Healthcare Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Prednisolone$2.7M 2

Product Portfolio — Top 6 by Export Value

Global Pharma Healthcare Private Limited exports 6 pharmaceutical products across 5 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Prednisolone	Respiratory	$2.7M	56	2.8%	9
2	Vildagliptin	Advanced Diabetes Medications	$146.5K	7	1.4%	14
3	Roxithromycin	Advanced Antibiotics	$135.0K	12	3.2%	5
4	Empagliflozin	Diabetes & Endocrine	$134.5K	11	2.0%	13
5	Repaglinide	Advanced Diabetes Medications	$48.3K	15	0.7%	6
6	Probiotics	Nutritional Supplements	$7.7K	3	0.1%	8

Global Pharma Healthcare Private Limited exports 6 pharmaceutical products across 5 therapeutic categories with a total export value of $3.2M. The top category is Respiratory (85.2% of portfolio), followed by Advanced Diabetes Medications (6.1%), indicating a concentrated portfolio with the top 5 products accounting for 99.8% of total export value.

Global Pharma Healthcare Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Global Pharma's primary manufacturing facility is situated in Chennai, Tamil Nadu, India. The plant covers over 75,000 square feet and is designed for large-scale, precision-controlled pharmaceutical production. It is certified by EU-GMP and WHO-GMP standards, reflecting the company's commitment to maintaining high-quality manufacturing processes. The facility is powered entirely by solar energy, demonstrating the company's dedication to sustainable manufacturing practices.

3Key Leadership

The leadership team at Global Pharma Healthcare Private Limited comprises:

Juma Venkatesh: Managing Director since July 26, 2006.

Manickam Kamalakannan: Director since April 6, 2012.

Balakrishnan Rajendran: Director since December 15, 2011.

These leaders bring extensive experience and expertise to the company's strategic direction and operations.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Global Pharma Healthcare Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Global Pharma Healthcare Private Limited has established a presence in several regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company's manufacturing facility in Chennai holds EU-GMP and WHO-GMP certifications, facilitating market access in these regions. Additionally, Global Pharma has received approvals from over 20 Ministries of Health worldwide, indicating a broad acceptance of its products in various international markets.

2Emerging Markets

Global Pharma Healthcare Private Limited has expanded its reach into emerging markets across Africa, Latin America, and Southeast Asia. The company's extensive product registrations and regulatory approvals from the European Union (EU-GMP) and the World Health Organization (WHO-GMP) have facilitated its entry into these regions. This strategic expansion underscores Global Pharma's commitment to improving access to affordable medications in diverse global markets.

3Geographic Strategy

Global Pharma Healthcare Private Limited demonstrates a diversified geographic strategy by exporting to over 40 countries across Asia, Africa, Latin America, the Commonwealth of Independent States (CIS), and the Middle East. This broad market presence mitigates concentration risk and positions the company to leverage growth opportunities in various regions. The company's commitment to quality, as evidenced by its EU-GMP and WHO-GMP certifications, supports its strategic direction of expanding into new markets while maintaining high standards.

Global Pharma Healthcare Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Global Pharma Healthcare Private Limited's manufacturing facility in Chennai is registered with the U.S. Food and Drug Administration (FDA). However, in October 2023, the FDA issued a warning letter to the company regarding deficiencies in its manufacturing practices, including inadequate testing of incoming materials and failure to ensure the suitability of active pharmaceutical ingredients and packaging materials. This indicates that while the company has access to the U.S. market, it must address these compliance issues to maintain its standing.

2WHO & EU GMP

Global Pharma Healthcare Private Limited's manufacturing facility in Chennai holds certifications from both the World Health Organization (WHO-GMP) and the European Union (EU-GMP). These certifications affirm the company's adherence to international quality standards in pharmaceutical manufacturing. Such certifications are crucial for market access in various regions and reflect the company's commitment to maintaining high-quality production processes.

3CDSCO & Indian Regulatory

Global Pharma Healthcare Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Global Pharma Healthcare Private Limited operates in a competitive pharmaceutical industry, facing competition from both domestic and international manufacturers. While specific market share data is not available, the company's extensive product portfolio and international certifications position it as a significant player in the market. The company's focus on quality, as evidenced by its EU-GMP and WHO-GMP certifications, and its commitment to sustainability, with a 100% solar-powered manufacturing facility, provide competitive advantages in the industry.

2Key Differentiators

Global Pharma Healthcare Private Limited's key differentiators include its extensive product portfolio, with over 700 product registrations across more than 40 countries, and its commitment to quality, demonstrated by EU-GMP and WHO-GMP certifications. Additionally, the company's manufacturing facility is powered entirely by solar energy, reflecting its dedication to sustainable practices.

3Strategic Position

Global Pharma Healthcare Private Limited's strategic direction focuses on expanding its global footprint by entering new markets and enhancing its product offerings. The company's adherence to international quality standards, such as EU-GMP and WHO-GMP certifications, supports its strategy of maintaining high-quality manufacturing processes. Addressing the FDA's concerns from the October 2023 warning letter is crucial for the company's future outlook and its ability to sustain and grow its market presence.

Buyer Due Diligence Brief — Evaluating Global Pharma Healthcare Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Global Pharma Healthcare Private Limited's supplier assessment practices have been called into question by the FDA, which cited inadequate testing of incoming materials and failure to ensure the suitability of active pharmaceutical ingredients and packaging materials. Addressing these issues is essential for the company to maintain its reputation for quality and reliability in the pharmaceutical industry.

2Certifications to Verify

Importers should verify the following certifications when considering products from Global Pharma Healthcare Private Limited:

EU-GMP Certification: Confirms compliance with European Good Manufacturing Practices.

WHO-GMP Certification: Indicates adherence to World Health Organization Good Manufacturing Practices.

ISO Certifications: Demonstrate compliance with international quality management standards.

Frequently Asked Questions — Global Pharma Healthcare Private Limited

How many pharmaceutical products does Global Pharma Healthcare Private Limited export from India?

Global Pharma Healthcare Private Limited exports 6 pharmaceutical products across 5 therapeutic categories. The top exports are Prednisolone ($2.7M), Vildagliptin ($146.5K), Roxithromycin ($135.0K), Empagliflozin ($134.5K), Repaglinide ($48.3K). Total export value is $3.2M.

What is Global Pharma Healthcare Private Limited's total pharmaceutical export value?

Global Pharma Healthcare Private Limited's total pharmaceutical export value is $3.2M, based on 104 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Global Pharma Healthcare Private Limited cover?

Global Pharma Healthcare Private Limited exports across 5 therapeutic categories. The largest are Respiratory (85.2%, 1 products), Advanced Diabetes Medications (6.1%, 2 products), Advanced Antibiotics (4.2%, 1 products).

Get Full Global Pharma Healthcare Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.